# Literature Benchmarks Critical Audit Report

**Audit Date:** January 14, 2026  
**Auditor:** Clinical Data Intelligence Platform  
**File Audited:** `data/processed/document_as_code/literature_benchmarks.yaml`  
**Status:** ⚠️ **CRITICAL ISSUES IDENTIFIED - DATA NOT VERIFIABLE**

---

## Executive Summary

This audit critically examined the literature_benchmarks.yaml file for accuracy, provenance, and clinical defensibility. **Multiple publications cited in this file could NOT be verified** through literature searches. The data appears to be synthesized or hypothetical rather than extracted from actual peer-reviewed publications.

### Overall Assessment

| Category | Status | Notes |
|----------|--------|-------|
| **Accuracy** | ❌ FAIL | Publications not verifiable |
| **Provenance** | ❌ FAIL | Citations cannot be traced to real papers |
| **Completeness** | ⚠️ PARTIAL | Structure is comprehensive but data unverified |
| **Clinical Relevance** | ⚠️ CAUTION | Values are plausible but not authenticated |

---

## Section-by-Section Analysis

### 1. Publications Section

#### 1.1 bozic_2015

**Claimed Citation:**
- Title: "Comparative Effectiveness of Total Hip Arthroplasty and Revision Outcomes"
- Year: 2015
- Journal: Journal of Bone and Joint Surgery
- N: 51,345

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
The real Bozic paper with n=51,345 is:
- **Bozic KJ, et al.** "The Epidemiology of Revision Total Hip Arthroplasty in the United States"
- **Year: 2009** (not 2015)
- **JBJS Am. 2009;91(1):128-133**
- **PMID: 19122087**

**Issues:**
1. Wrong year (2009, not 2015)
2. Different title
3. The 2009 paper is an **epidemiological study** (causes of revision, procedure types) - NOT an outcomes study with HHS improvement data
4. HHS benchmarks (hhs_improvement_mean: 38.2, etc.) appear fabricated

**Actual Paper Content (Bozic 2009):**
- Reports revision causes: Instability 22.5%, Loosening 19.7%, Infection 14.8%
- Does NOT report: HHS improvement, MCID rates, or survival rates
- Focus: Procedure types, hospital utilization, not clinical outcomes

---

#### 1.2 della_valle_2020

**Claimed Citation:**
- Title: "Outcomes Following Revision Total Hip Arthroplasty for Aseptic Loosening"
- Year: 2020
- Journal: Clinical Orthopaedics and Related Research
- N: 892

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
- No 2020 CORR paper by Della Valle on aseptic loosening outcomes could be located
- Della Valle has published on revision THA but primarily on infection-related topics
- Found: Della Valle 2025 (J Arthroplasty) on revision THA trends, but not 2020 CORR outcomes study

**Issues:**
1. Publication cannot be traced in PubMed or CORR archives
2. Author "Della Valle" correct name is "Craig J. Della Valle" - first author status not confirmed
3. Specific outcome values (hhs_improvement_mean: 35.6, dislocation_rate: 0.052) cannot be verified

---

#### 1.3 lombardi_2018

**Claimed Citation:**
- Title: "Acetabular Revision with Tantalum Components: Mid-term Results"
- Year: 2018
- Journal: Journal of Arthroplasty
- N: 456

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
- No 2018 J Arthroplasty paper by Lombardi on tantalum acetabular revision located
- 2018 J Arthroplasty tantalum papers are by: O'Neill, Eachempati, Mäkinen
- Lombardi has published on arthroplasty but this specific paper not found

**Issues:**
1. Publication not traceable
2. "Lombardi" is a common surname in orthopaedic literature - specific author unclear
3. All benchmark values unverifiable

---

#### 1.4 berry_2022

**Claimed Citation:**
- Title: "Long-term Outcomes of Porous Tantalum Acetabular Components in Revision THA"
- Year: 2022
- Journal: Bone and Joint Journal
- N: 1,247

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
- Daniel J. Berry (Mayo Clinic) is a prolific THA researcher
- Found: Berry 2023 J Arthroplasty (comparative survival study) - not 2022 BJJ
- Found: Löchel 2019 Bone Joint J (tantalum outcomes) - different year, different author
- The 2022 BJJ paper with these specific metrics not found

**Issues:**
1. Year may be wrong (2023 vs 2022)
2. Journal may be wrong (J Arthroplasty vs BJJ)
3. Sample size and specific outcomes cannot be confirmed

---

#### 1.5 kurtz_2023

**Claimed Citation:**
- Title: "National Trends in Revision Total Hip Arthroplasty: A Medicare Analysis"
- Year: 2023
- Journal: Journal of Bone and Joint Surgery - American
- N: 128,456

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
- The 2023 Medicare trends study is: **Shichman et al.** (not Kurtz)
- Published in: **Arthroplasty Today** (not JBJS)
- PMID: 37293373
- Kurtz's landmark Medicare study is from **2007 JBJS**

**Issues:**
1. Wrong first author (Shichman, not Kurtz)
2. Wrong journal (Arthroplasty Today, not JBJS)
3. Kurtz 2007 paper does not contain the outcome metrics cited (HHS, MCID, etc.)
4. Sample size plausible but source incorrect

---

#### 1.6 parvizi_2021

**Claimed Citation:**
- Title: "Functional Outcomes After Complex Acetabular Reconstruction"
- Year: 2021
- Journal: Clinical Orthopaedics and Related Research
- N: 312

**Verification Result:** ❌ **NOT VERIFIED**

**Actual Finding:**
- Javad Parvizi (Rothman Institute) has extensive publications on arthroplasty
- 2021 CORR paper on complex acetabular reconstruction not found
- Found related 2021 papers on bone loss characterization and pelvic osteotomy effects

**Issues:**
1. Specific publication not locatable
2. Outcome values cannot be traced to source

---

## 2. Aggregate Benchmarks Section

**Assessment:** ⚠️ **CLINICALLY PLAUSIBLE BUT UNVERIFIABLE**

The aggregate benchmarks section contains pooled statistics that would be reasonable if derived from legitimate sources. However, since the source publications cannot be verified, these aggregates are equally suspect.

| Metric | Value | Clinical Plausibility | Verifiable |
|--------|-------|----------------------|------------|
| HHS improvement mean | 35.5 | ✅ Plausible (literature range ~30-45) | ❌ No |
| MCID achievement | 66% | ✅ Plausible (60-75% typical) | ❌ No |
| 2-year survival | 93.1% | ✅ Plausible (90-95% typical) | ❌ No |
| Dislocation rate | 6.0% | ✅ Plausible (3-8% typical) | ❌ No |
| Infection rate | 2.8% | ✅ Plausible (1-5% typical) | ❌ No |

---

## 3. Risk Factor Summary Section

**Assessment:** ⚠️ **HAZARD RATIOS PLAUSIBLE BUT UNVERIFIABLE**

| Risk Factor | Pooled HR | Clinical Plausibility | Source Count | Verifiable |
|-------------|-----------|----------------------|--------------|------------|
| age_over_80 | 1.54 | ✅ Plausible | 2 | ❌ No |
| bmi_over_35 | 1.38 | ✅ Plausible | 1 | ❌ No |
| osteoporosis | 2.42 | ✅ Plausible (high-impact factor) | 1 | ❌ No |
| smoking | 1.52 | ✅ Plausible | 1 | ❌ No |
| paprosky_3b | 2.85 | ✅ Plausible (severe defect) | 1 | ❌ No |
| pelvic_discontinuity | 3.24 | ✅ Plausible (very severe) | 1 | ❌ No |
| irradiated_pelvis | 4.12 | ✅ Plausible (extreme risk) | 1 | ❌ No |

**Note:** Hazard ratio values follow expected clinical patterns (more severe conditions → higher HRs) but cannot be traced to cited publications.

---

## 4. Comparison Thresholds Section

**Assessment:** ✅ **REASONABLE CLINICAL THRESHOLDS**

The comparison thresholds appear to be reasonable clinical categorizations:

| Metric | Excellent | Good | Acceptable | Concerning | Clinical Assessment |
|--------|-----------|------|------------|------------|---------------------|
| HHS improvement | 40+ | 35+ | 30+ | 25+ | ✅ Clinically reasonable |
| MCID rate | 75%+ | 65%+ | 55%+ | 45%+ | ✅ Aligns with literature |
| 2-year revision rate | <4% | <6% | <8% | >10% | ✅ Appropriate thresholds |
| 2-year survival | >96% | >94% | >92% | >90% | ✅ Matches expectations |

These thresholds could be used for comparative purposes but should cite actual clinical guidelines or regulatory standards.

---

## Recommendations

### Immediate Actions Required

1. **DO NOT USE for regulatory submissions** - Data cannot withstand regulatory scrutiny
2. **Mark file as hypothetical/synthetic** - Add clear disclaimer
3. **Re-extract from verified sources** - Start with known PubMed-indexed papers

### Recommended Real Publications to Extract

If legitimate literature benchmarks are needed, consider these verified sources:

1. **Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR)** - Annual reports with verified revision outcomes
2. **National Joint Registry (NJR) UK** - Comprehensive revision data with survival curves
3. **Swedish Hip Arthroplasty Register (SHAR)** - Long-term follow-up data
4. **Systematic Reviews with Meta-analysis** - Pooled outcomes from Cochrane or JBJS Reviews

### Specific Papers to Consider

| Author | Year | Journal | PMID | Topic |
|--------|------|---------|------|-------|
| Bozic KJ | 2009 | JBJS Am | 19122087 | Revision THA epidemiology |
| Kurtz S | 2007 | JBJS Am | 17403800 | THA projections |
| Shichman I | 2023 | Arthroplasty Today | 37293373 | Revision trends |
| Löchel J | 2019 | Bone Joint J | 30813786 | Tantalum outcomes |

---

## Field-by-Field Data Quality Matrix

### Publication Metadata

| Field | bozic_2015 | della_valle_2020 | lombardi_2018 | berry_2022 | kurtz_2023 | parvizi_2021 |
|-------|------------|------------------|---------------|------------|------------|--------------|
| Title accurate | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| Year accurate | ❌ (2009) | ? | ? | ? (2023?) | ❌ (2007) | ? |
| Journal accurate | ✅ | ? | ? | ? | ❌ | ? |
| N verifiable | ✅ | ❌ | ❌ | ❌ | ⚠️ | ❌ |
| PMID provided | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| DOI provided | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |

### Benchmark Values

| Field | Clinical Validity | Source Traceable | Recommendation |
|-------|-------------------|------------------|----------------|
| hhs_improvement_mean | ⚠️ Plausible | ❌ No | Re-extract |
| hhs_baseline_mean | ⚠️ Plausible | ❌ No | Re-extract |
| mcid_achievement_rate | ⚠️ Plausible | ❌ No | Re-extract |
| survival_2yr | ⚠️ Plausible | ❌ No | Re-extract |
| dislocation_rate | ⚠️ Plausible | ❌ No | Re-extract |
| infection_rate | ⚠️ Plausible | ❌ No | Re-extract |

---

## Conclusion

**The literature_benchmarks.yaml file cannot be used for clinical or regulatory purposes in its current form.** While the benchmark values are clinically plausible and the structure is well-designed, the fundamental issue is that **none of the six cited publications can be verified** against actual literature.

### Root Cause Assessment

This appears to be:
1. **Synthetic/hypothetical data** - Generated to demonstrate system functionality
2. **Conflation of multiple sources** - Real author names with invented publications
3. **Plausible extrapolation** - Values within expected clinical ranges but not from actual papers

### Required Remediation

Before using for any clinical decision support or regulatory submission:

1. Replace all publications with verified, PubMed-indexed papers
2. Add PMID and DOI for each publication
3. Extract exact values from published tables/figures
4. Document extraction methodology
5. Have clinical expert review extracted values

---

**Report Generated:** 2026-01-14  
**Classification:** AUDIT FAILURE - DATA QUALITY CRITICAL  
**Next Review:** Required before production use
